REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Oncolog Udrea SRL (Romania)

Main Activities: Ambulatory Health Care Services
Full name: Oncolog Udrea SRL Profile Updated: February 05, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Oncolog Udrea SRL is an enterprise in Romania, with the main office in CLUJ-NAPOCA. The enterprise operates in the Ambulatory Health Care Services industry. The enterprise was incorporated on January 14, 2016. 28 (2025) employees currently work for Oncolog Udrea SRL. There was a net sales revenue increase of 204.88% reported in Oncolog Udrea SRL’s latest financial highlights for 2024. A growth of 1.16% was recorded in its total assets. Oncolog Udrea SRL’s net profit margin decreased by 37.32% in 2024.

Headquarters
Bulevardul Muncii Nr. 96
CLUJ-NAPOCA; Cluj; Postal Code: 400641

Contact Details: Purchase the Oncolog Udrea SRL report to view the information.

Basic Information
Total Employees:
Purchase the Oncolog Udrea SRL report to view the information.
Registered Capital:
Purchase the Oncolog Udrea SRL report to view the information.
Financial Auditors:
Purchase the Oncolog Udrea SRL report to view the information.
Incorporation Date:
January 14, 2016
Key Executives
Purchase this report to view the information.
Administrator
Purchase this report to view the information.
Administrator
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Oncolog Udrea SRL report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
204.88%▲
Total operating revenue
292.28%▲
Operating Profit/Loss (EBIT)
-31.21%▼
EBITDA
75.75%▲
Net Profit/Loss for the Period
-46.39%▼
Total Assets
1.16%▲
Total Equity
32.29%▲
Operating Profit Margin (ROS)
-36.33%▼
Net Profit Margin
-37.32%▼
Return on Equity (ROE)
-35.83%▼
Quick Ratio
0.02%▲
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo